Cognitive-Behavioral Therapy for Pain and Opioid Dependence in Methadone Maintenance Treatment

Sponsor
Yale University (Other)
Overall Status
Completed
CT.gov ID
NCT01334580
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)
40
1
2
41
1

Study Details

Study Description

Brief Summary

This study involves the comparison of two treatment approaches for patients with chronic pain who are entering methadone maintenance treatment (MMT) for opioid addiction: (a) an integrated counseling that addresses both chronic pain and opioid dependence(POD)and (b) a counseling intervention that addresses opioid dependence only.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive-Behavioral Therapy for Pain and Opioid Dependence
  • Behavioral: Methadone Drug Counseling
Phase 1

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Cognitive-Behavioral Therapy and Methadone Drug Counseling for Methadone-Maintained Patients With Co-occurring Chronic Pain and Opioid Dependence
Study Start Date :
Apr 1, 2011
Actual Primary Completion Date :
Sep 1, 2014
Actual Study Completion Date :
Sep 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Methadone Drug Counseling

Methadone Drug Counseling is provided by skilled drug counselors over a 12 week period and focuses on cessation of illicit drugs

Behavioral: Methadone Drug Counseling
Methadone Drug Counseling (MDC)is provided by skilled drug counselors over a 12-week period. The primary goal of MDC is cessation of illicit drugs.

Experimental: Cognitive-Behavioral Therapy for Pain and Opioid Dependence

CBT is provided by skilled psychologists in weekly sessions for 12 weeks and focuses on reducing illicit drug use and increasing pain management.

Behavioral: Cognitive-Behavioral Therapy for Pain and Opioid Dependence
CBT is provided by skilled psychologists in weekly sessions for 12 weeks and focuses on reducing illicit drug use and increasing pain management.

Outcome Measures

Primary Outcome Measures

  1. Pain reduction [16 weeks]

  2. Reduce illicit opioid use [16 weeks]

Secondary Outcome Measures

  1. Finalization of treatment manuals [16 weeks]

  2. Development and modification of therapy training and process rating measures [16 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years of age or older

  • prescription opioid or heroin addiction

  • moderate to severe chronic pain

  • enrolled in methadone maintenance at the APT Foundation for opioid addiction

  • understand English

Exclusion Criteria:
  • current suicide or homicide risk

  • life-threatening or unstable medical problem

Contacts and Locations

Locations

Site City State Country Postal Code
1 Methadone Research Unit New Haven Connecticut United States 06519

Sponsors and Collaborators

  • Yale University
  • National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Declan Barry, PhD, Yale University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yale University
ClinicalTrials.gov Identifier:
NCT01334580
Other Study ID Numbers:
  • 0703002496_B
  • K23DA024050-03
First Posted:
Apr 13, 2011
Last Update Posted:
Apr 3, 2020
Last Verified:
Apr 1, 2020
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 3, 2020